Every amazing idea comes from our brilliant people.
In Memory and Tribute
Professor Tian-Lu Cheng made extraordinary contributions to antibody drug research and precision medicine, laying the foundation of PrecisemAb’s technological innovation.Although he has left us, his vision for innovation, scientific spirit, and commitment to human health will continue to inspire us on our journey forward.We deeply mourn his passing and pay our highest respect and heartfelt tribute to his legacy.
/ In Memoriam /
Founder
Tian-Lu Cheng 1967 - 2024
Chair Professor / Chief Scientific Officer
Professor Tian-Lu Cheng dedicated 25 years to the field of antibody engineering and was the inventor of Universal Antibody Lock. He served as the Chief Scientific Officer at PrecisemAb and was widely recognized as an authority in antibody research and development in Taiwan.During his career, he acquired 18 international patents and completed 135 technology transfers, generating over 300 million NT dollars in royalties.
Career and Contributions
2018 – 2024 Chair Professor, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University 2024 Vice Chancellor, Kaohsiung Medical University 2018 – 2021 Provost, Office of Research and Development, Kaohsiung Medical University 2015 – 2018 Associate Dean, College of Medicine, Kaohsiung Medical University
Co-founder & CSO
Tian-Lu Cheng Chair Professor†
Co-founder & CEO
Yun-chi Lu, Ph.D.
Co-founder & CTO
Yi-An Cheng, Ph.D.
COO
Willie Lin, Ph.D.
Chief Scientific Advisor
Peter Senter, Ph.D.
Director of Product Development and Quality Management